Abstract | BACKGROUND: METHODS: RESULTS: HbA1c and FPG levels did not change 12 or 24 weeks after the switch; however, the 2h-PPG level decreased from 218.0±67.5 mg/dL at baseline to 197.1±69.9 mg/dL at 12 weeks and 192.3±67.4 mg/dL at 24 weeks after switching drugs (P=0.045, P=0.018, respectively). All but one patient no longer experienced hypoglycemia after discontinuing glimepiride. In a multivariate logistic regression analysis, a high homeostasis model assessment of insulin resistance and low baseline HbA1c level were independent predictors of an HbA1c ≤7% after switching to sitagliptin. CONCLUSION:
|
Authors | Hyun Min Kim, Jung Soo Lim, Byung Wan Lee, Eun Seok Kang, Hyun Chul Lee, Bong Soo Cha |
Journal | Endocrinology and metabolism (Seoul, Korea)
(Endocrinol Metab (Seoul))
Vol. 30
Issue 1
Pg. 84-91
(Mar 27 2015)
ISSN: 2093-596X [Print] Korea (South) |
PMID | 25325279
(Publication Type: Journal Article)
|